Should a 63-year-old male with a history of prosthetic mitral valve on Coumadin (warfarin), hypertension, previous stroke, systolic heart failure with reduced ejection fraction (EF 50%) and carotid artery stenosis obtain cardiac clearance prior to surgery under anesthesia for removal of a large lipoma?

From the Guidelines

A 63-year-old male with a prosthetic mitral valve on Coumadin, hypertension, history of stroke, systolic heart failure with an ejection fraction of 50%, and carotid artery stenosis should absolutely obtain clearance from his cardiologist before undergoing surgery under anesthesia for lipoma removal. This patient has multiple significant cardiovascular risk factors that could complicate surgery and anesthesia. The cardiologist will need to evaluate the patient's current cardiac status, optimize medication management (particularly anticoagulation with Coumadin), and provide specific recommendations for perioperative care.

Key Considerations

• Management of anticoagulation is especially critical, as stopping Coumadin increases thrombotic risk with the prosthetic valve, while continuing it increases bleeding risk during surgery, as highlighted in the 2021 guidelines from the British Society of Gastroenterology and European Society of Gastrointestinal Endoscopy 1.
• The patient's prosthetic mitral valve and history of stroke place him at high risk for thromboembolism, suggesting the need for careful consideration of anticoagulation management during the perioperative period, in line with recommendations for patients with high risk of thromboembolism 1.
• The history of carotid stenosis and previous stroke increases the risk of perioperative neurological complications, while heart failure raises concerns about fluid management and hemodynamic stability during anesthesia.
• Preoperative cardiac clearance will help establish the safest approach to surgery, potentially including additional monitoring or medication adjustments to reduce perioperative cardiovascular and cerebrovascular complications, as discussed in the acc/aha 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery 1.

Perioperative Care

• The cardiologist may recommend a bridging strategy with heparin or low molecular weight heparin to manage anticoagulation during the perioperative period, considering the patient's high risk of thromboembolism 1.
• Close monitoring of the patient's cardiac status and anticoagulation levels will be necessary to minimize the risk of complications.
• Collaboration between the cardiologist, anesthesiologist, and surgeon will be essential to develop a comprehensive perioperative plan that addresses the patient's complex cardiovascular risks.